Cargando…

Long-term Follow up of Mesenchymal Hamartoma of Liver- Single Center Study

BACKGROUND/AIM: Mesenchymal hamartoma of liver (MHL) is a rare liver tumor of childhood. About 200 cases have been reported till now. Most of the work on MHL is limited to case reports and there are not many long term follow-up studies. We present our 20 years of experience with this uncommon entity...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Anand, Gangopadhyay, Ajay N., Sharma, Shiv P., Kumar, Vijayendra, Gupta, Dinesh K., Gopal, Saroj C., Patne, Shashikant C.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099075/
https://www.ncbi.nlm.nih.gov/pubmed/21196648
http://dx.doi.org/10.4103/1319-3767.74449
_version_ 1782204030536122368
author Pandey, Anand
Gangopadhyay, Ajay N.
Sharma, Shiv P.
Kumar, Vijayendra
Gupta, Dinesh K.
Gopal, Saroj C.
Patne, Shashikant C.
author_facet Pandey, Anand
Gangopadhyay, Ajay N.
Sharma, Shiv P.
Kumar, Vijayendra
Gupta, Dinesh K.
Gopal, Saroj C.
Patne, Shashikant C.
author_sort Pandey, Anand
collection PubMed
description BACKGROUND/AIM: Mesenchymal hamartoma of liver (MHL) is a rare liver tumor of childhood. About 200 cases have been reported till now. Most of the work on MHL is limited to case reports and there are not many long term follow-up studies. We present our 20 years of experience with this uncommon entity. This study aims to highlight clinical features, diagnosis and treatment of MHL. MATERIALS AND METHODS: All patients with a diagnosis of MHL in last 20 years were included in this retrospective study. The patients were evaluated clinically, radiologically and pathologically. RESULTS: The total number of patients with a diagnosis of MHL was nine. Mean age of the patients was 19.89 ± 2.75 months. Right lobe was involved in eight patients. The prominent clinical features were distension of abdomen and anorexia. Surgical options used were hepatic lobectomy, wedge resection and enucleation. Histopathology of the specimens showed cysts of variable size with normal hepatocytes, bile ducts and connective tissue stroma. Overall mortality was one (11.11%). CONCLUSION: MHL is a benign tumor that can present with various clinical features. It should be differentiated carefully from other liver masses especially malignant ones. The diagnosis can be made with the help of radiology and histopathology. Adequate resection is curative in most of the cases and long-term follow up is satisfactory.
format Text
id pubmed-3099075
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30990752011-05-23 Long-term Follow up of Mesenchymal Hamartoma of Liver- Single Center Study Pandey, Anand Gangopadhyay, Ajay N. Sharma, Shiv P. Kumar, Vijayendra Gupta, Dinesh K. Gopal, Saroj C. Patne, Shashikant C. Saudi J Gastroenterol Original Article BACKGROUND/AIM: Mesenchymal hamartoma of liver (MHL) is a rare liver tumor of childhood. About 200 cases have been reported till now. Most of the work on MHL is limited to case reports and there are not many long term follow-up studies. We present our 20 years of experience with this uncommon entity. This study aims to highlight clinical features, diagnosis and treatment of MHL. MATERIALS AND METHODS: All patients with a diagnosis of MHL in last 20 years were included in this retrospective study. The patients were evaluated clinically, radiologically and pathologically. RESULTS: The total number of patients with a diagnosis of MHL was nine. Mean age of the patients was 19.89 ± 2.75 months. Right lobe was involved in eight patients. The prominent clinical features were distension of abdomen and anorexia. Surgical options used were hepatic lobectomy, wedge resection and enucleation. Histopathology of the specimens showed cysts of variable size with normal hepatocytes, bile ducts and connective tissue stroma. Overall mortality was one (11.11%). CONCLUSION: MHL is a benign tumor that can present with various clinical features. It should be differentiated carefully from other liver masses especially malignant ones. The diagnosis can be made with the help of radiology and histopathology. Adequate resection is curative in most of the cases and long-term follow up is satisfactory. Medknow Publications 2011 /pmc/articles/PMC3099075/ /pubmed/21196648 http://dx.doi.org/10.4103/1319-3767.74449 Text en © Saudi Journal of Gastroenterology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Pandey, Anand
Gangopadhyay, Ajay N.
Sharma, Shiv P.
Kumar, Vijayendra
Gupta, Dinesh K.
Gopal, Saroj C.
Patne, Shashikant C.
Long-term Follow up of Mesenchymal Hamartoma of Liver- Single Center Study
title Long-term Follow up of Mesenchymal Hamartoma of Liver- Single Center Study
title_full Long-term Follow up of Mesenchymal Hamartoma of Liver- Single Center Study
title_fullStr Long-term Follow up of Mesenchymal Hamartoma of Liver- Single Center Study
title_full_unstemmed Long-term Follow up of Mesenchymal Hamartoma of Liver- Single Center Study
title_short Long-term Follow up of Mesenchymal Hamartoma of Liver- Single Center Study
title_sort long-term follow up of mesenchymal hamartoma of liver- single center study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099075/
https://www.ncbi.nlm.nih.gov/pubmed/21196648
http://dx.doi.org/10.4103/1319-3767.74449
work_keys_str_mv AT pandeyanand longtermfollowupofmesenchymalhamartomaofliversinglecenterstudy
AT gangopadhyayajayn longtermfollowupofmesenchymalhamartomaofliversinglecenterstudy
AT sharmashivp longtermfollowupofmesenchymalhamartomaofliversinglecenterstudy
AT kumarvijayendra longtermfollowupofmesenchymalhamartomaofliversinglecenterstudy
AT guptadineshk longtermfollowupofmesenchymalhamartomaofliversinglecenterstudy
AT gopalsarojc longtermfollowupofmesenchymalhamartomaofliversinglecenterstudy
AT patneshashikantc longtermfollowupofmesenchymalhamartomaofliversinglecenterstudy